JaniceJean PhillipsDutcherMD

Oncology • Bronx, NY

Genitourinary Oncology, Hematologic Oncology, Melanoma

Professor of Medicine, New York Medical College

Join to view full profile

Dr. Dutcher is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dutcher's full profile

Already have an account?

Office
750 Kappock Street
# 511
Bronx, NY 10463
Phone+1 914-316-7809

Summary

Dr. Janice Dutcher is an oncologist in New York, NY. She received her medical degree from University of California, Davis, School of Medicine and completed an oncology fellowship at the National Cancer Institute. She has been in practice 42 years. She also speaks multiple languages, including Spanish. She specializes in genitourinary oncology, hematologic oncology, and melanoma and is experienced in hematologic oncology, breast cancer, mohs micrographic surgery, urologic oncology, and melanoma and cutaneous malignancies. She has more than 100 publications and over 500 citings.

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1978 - 1981
Rush University Medical CenterResidency, Internal Medicine, 1976 - 1978
Rush University Medical CenterInternship, Internal Medicine, 1975 - 1976
University of California, Davis, School of MedicineClass of 1975
University of UtahBA, Magna Cum Laude, 1971

Certifications & Licensure

NY State Medical License 1982 - 2025
MD State Medical License 1978 - 2018
IL State Medical License 1976 - 1984
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Outstanding Alumnus UC Davis School of Medicine, 1988
Recipient of the Women of Distinction Health Care Services 2008
Who's Who of American Women 1997
Who's Who in the East 1995
Who's Who in America 1995
Recipient, Young Investigator Eastern Cooperative Oncology Group, 1993
Who's Who in the World 1993
Who's Who in Science and Engineering 1992
Recipient, First Prize for Clinical Research Henry C. Moses Award, Montefiore Medical Center, 1989
First Recipient of the Distinguished Alumnus University of California, Davis School of Medicine, 1988
Finalist, Beecham Southern Meeting and Southern Society for Clinical Investigation, 1983
Fellow Leukemia Society of America, 1983, 1985
Member Alpha Omega Alpha, 1975
Lange Medical Publishers 1975
Member Phi Beta Kappa, 1971
Member Phi Kappa Phi, 1971
Sterling Scholar in General Scholarship State of Utah, 1968
Presidential Scholar from State of Utah White House by invitation of President Lyndon B. Johnson, 1968
National Merit Finalist and Scholar 1968
Alpha Lambda Delta Freshman Women Honor Society, 1968, 1970
Top MD Consumers Checkbook
Whos Who in Medicine and Healthcare Marquis Whos Who
Join now to see all

Clinical Trials

Arsenic Trioxide in Treating Patients With Recurrent or Refractory Acute Leukemia, Chronic Myeloide Leukemia, Myelodysplasia, Lymphoma, or Myeloma Start of enrollment: 1997 Nov 01
Unknown status
Phase 2
Bevacizumab and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer Start of enrollment: 2005 Sep 01
Unknown status
Phase 2
The High-Dose Aldesleukin (IL-2) "Select" Trial for Patients With Metastatic Renal Cell Carcinoma Start of enrollment: 2006 Nov 01
Completed
Phase 2

Publications & Presentations

PubMed

79 citations
Current status of interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma.
Janice P. Dutcher
Oncology. 2002-11-01
31 citations
Acute renal dysfunction during interleukin-2 treatment: suggestion of an intrinsic renal lesion.
Craig L. Shalmi, Janice P. Dutcher, Donald A. Feinfeld, K. J. Chun, Khalid Saleemi
Journal of Clinical Oncology. 1990-11-01
1456 citations
High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993
Michael B. Atkins, Michael T. Lotze, Janice P. Dutcher, Richard I. Fisher, Geoffrey R. Weiss
Journal of Clinical Oncology. 1999-07-01

Journal Articles

Alloimmunization following platelet transfusion: The absence of a dose-response relationship.
Dutcher JP, Schiffer CA, Aisner J, Wiernik PH, Blood 1981; 57; 395-398
Rapid migration of Indium-111-labelled granulocytes to sites of infection.
Dutcher JP, Schiffer CA, Johnston GS, N Engl J Med 1981; 304; 586-589
Long-term follow-up of patients with leukemia receiving platelet transfusions: Identification of a large group of patients who do not become alloimmunized.
Dutcher JP, Schiffer CA, Aisner J, Wiernik PH, Blood 1981; 58; 1007-1011
Histocompatible platelet transfusion for patients with leukemia.
Schiffer CA, Dutcher JP, Hogge DE, Aisner J, Plasma Therapy and Transfusion Technology 1982; 3; 272-28l
Platelet cryopreservation using dimethylsulfoxide.
Schiffer CA, Aisner J. Dutcher JP, Annals N Y Academy of Science 1983; 411; 161-169
Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusion.
Hogge DE, Dutcher JP, Aisner J, Schiffer CA, Amer J Hematol 1983; 14; 363-369
Serial CT of malignant pleural mesothelioma.
Mirvis S, Dutcher JP, Haney PJ, Whitley NO, Aisner J, Am J Radiology 1983; 140; 665-670
Potential HLA matched platelet donor availability for alloimmunized patients.
Schiffer CA, Keller C, Dutcher JP, Aisner J, Hogge D, Wiernik PH, Transfusion 1983; 23; 286-289
Adriamycin or Daunorubicin in combination with cytosine arabinoside for the treatment of acute nonlymphocytic leukemia.
Wiernik PH, Riggs C Jr, Dutcher JP, Drugs Exper Clin Res 1983; 9; 403-406
Alloimmunization prevents the migration of transfused Indium-111-labeled granulocytes to sites of infection.
Dutcher JP, Schiffer CA, Johnston GS, Papenberg D, Daly PA, Aisner J, Wiernik PH, Blood 1983; 62; 354-360
A randomized trial of leukocyte-depleted platelet transfusion to modify alloimmunization in patients with leukemia.
Schiffer CA, Dutcher JP, Aisner J, Hogge D, Wiernik PH, Reilly JP, Blood 1983; 62; 815-820
Sustained post-transfusion granulocyte count increments following transfusion of leukocytes obtained from donors with chronic myelogenous leukemia.
Schiffer CA, Aisner J, Dutcher JP, Wiernik PH, Am J Hematol 1983; 15; 65-74
Ethiodized oil emulsion 13 in computed tomography of hepatoma.
Dutcher JP, Haney PJ, Whitley NO, Finley R, Pearl P, Didolkar MS, Wiernik PH, J Clin Oncol 1984; 2; 118-123
The ineffectiveness of random donor platelet transfusion in splenectomized alloimmunized recipients.
Hogge DE, Dutcher JP, Aisner J, Schiffer CA, Blood 1984; 64; 253-256
High dose intravenous gammaglobulin in alloimmunized platelet transfusion recipients.
Schiffer CA, Hogge DE, Aisner J, Dutcher JP, Lee EJ, Papenberg D, Blood 1984; 64; 937-940
Incidence of thrombocytopenia and bleeding among patients with solid tumors.
Dutcher JP, Schiffer CA, Aisner J, O'Connell BA, Levy C, Kendall JA, Wiernik PH, Cancer 1984; 53; 557-562
Decreased sensitivity of early imaging with In-111 oxine-labeled leukocytes in detection of occult infection.
Dutcher JP, J Nuc Med 1984; 25; 1150-1151
Terminal transferase positive acute promyelocytic leukemia: In vitro differentiation of a T-lymphocytic/promyelocytic hybrid phenotype.
Paietta E, Dutcher JP, Wiernik PH, Blood 1985; 65; 107-114
Phase I clinical and pharmacokinetic study of taxol.
Wiernik PH, Schwartz EL, Strauman JJ, Dutcher JP, Lipton RB, Paietta E, Cancer Res 1987; 47; 2486-2493
Phase I trial of taxol given as a 24-hour infusion every 21 days: Responses observed in metastatic melanoma.
Wiernik PH, Schwartz EL, Einzig A, Strauman JJ, Lipton RB, Dutcher JP, J Clinical Oncology 1987; 5; 1232-1239
Severe hypovitaminosis C occurring as the result of adoptive immunotherapy with high-dose interleukin-2 and lymphokine-activated killer cells.
Marcus SL, Dutcher JP, Paietta E, Ciobanu N, Strauman J, Wiernik PH, Hutner SH, Frank O, Baker H, Cancer Research 1987; 47; 4208-4212
Mitoxantrone and Ara-C in previously treated patients with acute myelogenous leukemia.
Paciucci PA, Dutcher JP, Cuttner J, Strauman JJ, Wiernik PH, Holland JF, Leukemia 1987; 1; 565-567
Hyperleukocytosis in adult acute nonlymphocytic leukemia: Impact on remission rate and duration and survival.
Dutcher JP, Schiffer CA, Wiernik PH, J Clin Oncol 1987; 5; 1364-1372
Quantitative sensory testing demonstrates that subclinical sensory neuropathy is prevalent in patients with cancer.
Lipton RB, Galer BS, Dutcher JP, Portenoy RK, Berger A, Arezzo JC, Mizruchi M, Wiernik PH, Schaumburg HH, Arch Neurol 1987; 44; 944-946
Phase II trial of recombinant alpha-2b-interferon and low dose cyclophosphamide in advanced melanoma and renal cell carcinoma.
Wadler S, Einzig AI, Dutcher JP, Ciobanu N, Laudau L, Wiernik PH, Am J Clin Oncol 1988; 11; 55-59
Join now to see all

Books/Book Chapters

Kelley’s Textbook of Internal Medicine.
Chapter: Approach to the Patient with Superior Vena Cava Syndrome
Page 1540 - 1543Dutcher JPEditors: H. David Humes.Lippincott, Willliams & Wilkins, Philadelphia, PAEdition 4,
Neoplastic Diseases of the Blood.
Chapter: Hematopoietic Growth Factors
Page 1123 - 1136Dutcher JPEditors: PH Wiernik, R Kyle, Goldman JM, JP Dutcher.Cambridge Pub, New YorkEdition 4,
Neoplastic Diseases of the Blood.
Chapter: Platelet and Granulocyte Transfusion
Page 1028 - 1048Dutcher JPEditors: PH Wiernik, R Kyle, Goldman JM, JP Dutcher.Cambridge Pub, New YorkEdition 4,
Clinical Geriatrics for Primary Care.
Chapter: Oncologic Disorders in Older Adults
Page 501 - 515Dutcher JP, Wiernik PHEditors: Dharmarajan T, Norman C.Parthenon Publishing
Best Practice of Medicine Praxis.
Chapter: Oncologic Emergencies
Gucalp R, Dutcher JP
Adult Leukemias.
Chapter: Supportive Care in Adult Leukemias
Page 307 - 342Dutcher JPEditors: P Wiernik.BC Decker Pub, Ontario, Canada
Harrison, Principles of Internal Medicine.
Chapter: Oncologic Emergencies
Page 642 - 650Gucalp R. and Dutcher JPEditors: Braunwald, Fauci, Kasper, Hauser, Longo, Jameson.McGraw-Hill, New YorkEdition 15,
Annals of Internal Medicine.
Chapter: Book Review, Transfusion Therapy: Clinical Principles and Practice
Page 133 - 572Dutcher JPEditors: P.D. Mintz.AABB Press
Medical Oncology.
Chapter: Book Review: Aplastic Anemia: Pathophysiology and Treatment
Page 17 - 248Dutcher JPEditors: H. Schrezenmeier and A. Bacigalupo.Cambridge University Press
Current Treatment Options in Oncology.
Chapter: Accelerated and Blastic Phase of Chronic Myeloid Leukemia
Page 51 - 62Dutcher JP and Wiernik PH
Kelley’s Textbook of Internal Medicine.
Chapter: Approach to the Patient with a Pathologic Fracture
Page 1567 - 1570Dutcher JPEditors: H. David Humes.Lippincott, Willliams & Wilkins, Philadelphia, PAEdition 4,
Kidney Cancer; Series.
Chapter: Interleukin-2 Based Therapy for Kidney Cancer
Page 155 - 172Dutcher JPEditors: R. Figlin.Steven Rosen; Kluwer Academic Publishers, Boston
Comprehensive Textbook of Genitourinary Oncology.
Chapter: Low-dose Interleukin-2 for Advanced Renal Cell Carcinoma
Page 218 - 233Bukowski R and Dutcher JPEditors: NJ Vogelzang, PT Scardino, WU Shipley, DS Coffey.Williams & WilkinsEdition 2,
Current Practice of Medicine, Vol 3.
Chapter: Oncologic Emergencies
Page 1313 - 1325Gucalp R and Dutcher JPEditors: RC Bone, WC Koller, J Faucett, J Pake, DS Ettinger.Churchill Livingstone, New YorkEdition 2,
Diagnostic and Therapeutic Advances in Hematologic Malignancies.
Chapter: Novel Biologic Approaches to Hematologic Malignancies
Page 275 - 306Dutcher JP and Wiernik PHEditors: M. Tallman, L. Gordon.Kluwer Internatl Press, Norwell, MA
Medical Management of Hematologic Malignant Disease.
Chapter: Therapy of Acute Myeloid Leukemia
Page 5 - 18Wiernik PH, Dutcher JPEditors: E Freireich.Marcel Dekker, New York
Harrison's Principles of Internal Medicine.
Chapter: Oncologic Emergencies
Page 627 - 634Gucalp R, Dutcher JPEditors: AS Fauci, E Braunwald, KJ Isselbacher, JD Wilson, JB Martin, DL Kasper, SL Hauser, DL Longo.McGraw Hill, New YorkEdition 14,
Current Problems in Cancer, Vol 21(6).
Chapter: Cardiovascular Toxicity with Cancer Chemotherapy
Page 301 - 360Frishman WH, Sung HM, Yee HCM, Keefe D, Einzig A, Dutcher JEditors: S D. Williamss.Mosby- Year Book, St Louis, MO
Apheresis: Principles and Practice.
Chapter: Autologous Adoptive Immunotherapy
Page 475 - 500Oleksowicz L, Malik U, Dutcher JPEditors: BC McLeod.AABB Press, Alexandria VA
Cardiovascular Pharmacotherapeutics.
Chapter: Cardiovascular Toxicity with Cancer Chemotherapy
Page 1479 - 1504Frishman WH, Sung HM, Yee HCM, Keefe D, Einzig A, Dutcher JEditors: WH Frishman and E Sonnenblick.McGraw-Hill, New York
Textbook of Internal Medicine.
Chapter: Approach to the Patient with a Pathologic Fracture
Page 1293 - 1295Dutcher JPEditors: WN Kelley.J.B. Lippincott, Philadelphia, PAEdition 3,
Harrison, Principles of Internal Medicine.
Chapter: Oncologic Emergencies
Gucalp R. and Dutcher JPEditors: DL Kasper, E Braunwald, AS Fauci, SL Hauser, DL Longo, JL Jameson.McGraw- Hill, New YorkEdition 18,
Heart and Lung.
Chapter: Book Review of Thoracic Oncology
Dutcher JPEditors: Roth JA, Ruckdeschel JC, Weisenburger TH.WB Saunders, Philadelphia, PA
Current Clinical Urology Series.
Chapter: Renal Cell Carcinoma: Clinical Management
Dutcher JPEditors: Steven C Campbell and Brian I Rini.Humana Press
Current Clinical Oncology Series.
Chapter: Targeted Therapeutics in Melanoma
Page 399 - 400Dutcher JPEditors: Thomas F Gajewski and F. Stephen Hodi.
Join now to see all

Abstracts/Posters

Cytogenetic and phenotypic evolution in a case of acute promyelocytic leukemia.
Paietta E, Papenhausen P, Dutcher JP, Wiernik PH, Cancer Genetics and Cytogenetics 1986; 21;181-182
Lymphoma with primary cardiac manifestations.
Gelman KM, Ben-Ezra JM, Steinschneider M, Keefe DL, Dutcher JP, Factor SM, Am Heart Journal 1986; 111; 808-811
Life-threatening hyperleukocytosis and pulmonary compromise after priming with rh-GMCSF in a patient with AML.
Einzig AI, Dutcher JP, Wiernik PH, J Clin Oncol 1995; 13; 304
Acute Non-Lymphocytic Leukemia.
Dutcher JP and Wiernik PH, American Society of Hematology Educational microfishe and manual
Some new drugs in acute nonlymphocytic leukemia (ANLL).
Wiernik PH, Dutcher JP, Proc 13th Int Cong Chemother 1983; 237; 52-55
Acute Leukemia.
Benson L, Dutcher JP, Wiernik PH, Booklet for the Leukemia Society of America
Introduction to Bone Marrow Transplant.
Gucalp R, Sparano J, Dutcher JP, Wiernik PH, Medical Oncology Volume 11, Albert Einstein Cancer Center, Bronx, NY
Efficacy of high dose interferon as adjuvant therapy in high risk melanoma: Overview of ECOG studies 1684 and 1690.
Dutcher JP, Kirkwood JM, Zeitschrift fur Hautkrankh, H+G 2000; 4(75); 220-223, Melanoma, Ruhr- University, Bochum
Renal Cell Carcinoma – Today’s Targeted Therapies Improving Tomorrow’s Outcomes.
Dutcher JP, Green RI, Moore SH, Continuing Education Newsletter for Nurses. Meniscus Educational Institute
Role of carbonic anhydrases in the progression of renal cell carcinoma subtypes: Proposal of a unified hypothesis.
Dorai T, Sawczuk I, Pastorek J, Wiernik PH, Dutcher JP, Cancer Investigation 2006; 24; 1-26
Alloimmunization following platelet transfusion: The absence of a dose response relationship.
Dutcher JP, Schiffer CA, Aisner J, Wiernik PH, Proc Am Soc Clin Oncol; 1980; 21:351
Localization of infection using Indium-labelled granulocytes in granulocytopenic patients.
Dutcher JP, Schiffer CA, Johnston GS, Rad Soc North Amer; 1980; 66:320
Effect of hyperleukocytosis in acute leukemia on remission rate, duration, and survival.
Dutcher JP, Schiffer CA, Wesley M, Wiernik PH, Proc Amer Soc Clin Oncol; 1981; 22:491
Localization of infection using Indium-111-labeled granulocytes in granulocytopenic patients.
Dutcher JP, Schiffer CA, Johnston GS, Sorandes TP, Proc Soc Nuc Med Mideastern
A clinical program of autologous frozen platelet transfusion.
Schiffer CS, Aisner J, Dutcher JP, Reilly J, Wiernik PH, Proc Am Assoc Blood Banks Transfusion; 1981; p 618
The effect of histocompatibility factors on the migration of transfused Indium-111-labeled granulocytes.
Dutcher JP, Schiffer CA, Johnston GS, Papenberg D. Daly PA, Aisner J, Wiernik PH, Blood; 1981; 58 (Suppl): 181a
Short-term engraftment following transfusion of leucocytes from patients with chronic myelogenous leukemia.
Schiffer CA, Aisner J, Dutcher JP, Wiernik PH, Blood; 1981; 58 (suppl):186a
Incidence of thrombocytopenia and bleeding among patients with solid tumors.
Dutcher JP, Schiffer CA, Aisner J, O'Connell BA, Levy C, Kendall JA, Wiernik PH, Proc Am Soc Clin Oncol; 1982; 1:62
Lymphocytotoxic antibody is a predictor of response to random donor platelet transfusion.
Hogge DE, Dutcher JP, Aisner J, Schiffer CA, Proc Am Soc Clin Oncol; 1982; 1:59
Pulmonary retention of Indium-111-labeled granulocytes in alloimmunized patients.
Dutcher JP, Fox JJ, Riggs C, Johnston GS, Schiffer CA, Blood; 1982; 60 (Suppl I):177a
A randomized trial of leukocyte depleted platelet transfusion to modify alloimmunization in patients with leukemia.
Schiffer CA, Dutcher JP, Aisner J, Hogge D, Wiernik PH, Reilly JP, Blood; 1982; 60 (Suppl I):182a
Indium-labeled granulocytes to evaluate histocompatibility factors in granulocyte transfusions.
Dutcher JP, Schiffer CA, Johnston GS, Papenberg D, Daly PA, Fox JJ, Aisner J, Wiernik PH, 3rd International Symposium on Therapy of Acute Leukemia, Rome; 1982; p125
Morphologic study of spleens taken from patients with acute non-lymphocytic leukemia (ANLL) in complete remission.
Sutherland J, Dutcher JP, Wiernik PH, 3rd International Symposium on Therapy of Acute Leukemia, Rome; 1982; p45
Intensive maintenance therapy (IMT) in acute non-lymphocytic leukemia.
Dutcher JP, Wiernik PH, Van Sloten K, Schiffer CA, Schimpff SC, Aisner J, Angelou JE, 3rd International Symposium on Therapy of Acute, Leukemia Rome; 1982; p39
Differences in individual species of intracellular acidic Dnase correlate with specific chromosomal abnormalities and with leukemia subtype.
Brown GE, Karpetsky TP, Testa JR, McFarland E, Dutcher J, Proc Amer Assoc Cancer Res; 1983; 24:40
Join now to see all

Lectures

Present-Day Management of Hodgkins Disease.
Congressos Integrados Latino-Americanos de Cancerologia. Sao Paulo, Brazil
Treatment of Acute Leukemia.
Congressos Integrados Latino-Americanos Cancerologia. Sao Paulo, Brazil
Hematologic Support of the Cancer Patient.
University of Maryland School of Medicine
The Effect of Alloimmunization on the Migration of 111In-labeled Granulocytes to Infected Sites.
Phagocyte Workshop, Washington, D.C
Ethiodized Oil Emulsion (EOE) 13 for CT Scanning of the Liver and Spleen.
Cancer Management Symposium, University of Maryland, Baltimore
Indications for Platelet Transfusion.
Annual Meeting - Michigan Blood Bank Association, Detroit, Michigan
New Approaches in the Treatment of Acute Leukemia.
State Hospital of St. Gallen, Switzerland
Pulmonary Retention of Indium-111-Labeled Granulocytes.
Phagocytologists Workshop, Washington D.C
Clinical Approach to Platelet Transfusion Therapy.
American Red Cross Blood Services, Central Ohio Region, Columbus, Ohio
Management of Acute Leukemia.
I Latin American Congress of Clinical Oncology of the UICC, Lima, Peru
Present Status of the Treatment of Acute Non-Lymphocytic Leukemia.
Latin American Congress of Clinical Oncology of the UICC, Lima, Peru
Neutropenia and Infections in Cancer.
Latin American Congress of Clinical Oncology of the UICC, Lima, Peru
Leukemia and Myeloproliferative Disorders.
American Society of Hematology
Transfusion Supportive Care.
Montefiore Medical Center, Manhattan, N.Y
Labeled Cells for Abscess and Thrombus Localization.
Albert Einstein College of Medicine/Montefiore Medical Center, Manhattan, NY
Transfusion Supportive Care.
Long Island Jewish Hospital, New York, NY
Methotrexate, Leukovorin Interactions.
Mercy Hospital, Pittsburgh, PA
Leukemia Treatment in the Elderly.
University of Maryland Cancer Center, Baltimore, MD
Management of Acute Non-Lymphocytic Leukemia.
Mt. Sinai Hospital and Medical Center, New York, NY
New Approaches in Oncology: Interleukin-2 and Bone Marrow Transplantation.
Bronx Lebanon Hospital, New York, NY
High Dose Methotrexate Therapy - Is More Better?
Oncology Grand Rounds, Wilford Hall Air Force Medical Center, San Antonio, TX
Platelet Transfusion Therapy in Oncology Patients.
San Antonio Blood Club, San Antonio, TX
Experimental Therapy for Melanoma: Interleukin-2 and Taxol.
The Melanoma Letter, Skin Cancer Foundation
Infection Management in Patients with Malignancy.
Our Lady of Mercy Hospital, Bronx, NY
Hematologic Complications of Malignancy.
Riverside Hospital, Red Bank, NJ
Join now to see all

Other

Controversies in Oncology: Editorial Comment: Perioperative blood transfusion and solid tumor recurrence - a review.
Dutcher JP, Cancer Investigation 1987; 5; 613-614
Meeting report: American Society of Clinical Oncology.
Dutcher JP, J Cancer Res Clin Oncol 1989; 115; 485-490
Principles of Transfusion Medicine.
Dutcher JP, Annals of Internal Medicine 1991; 115:238-239
Future directions of biologic therapy in cancer.
Dutcher JP, Hospital Formulary 1992; 27:694-707
Interferons and interleukins in cancer therapy.
Dutcher JP, Mediguide to Oncology 1992; 12(3):1- 11
Angiogenesis and melanoma.
Dutcher JP, Current Oncology Reports 2001; 3; 353-358
Kidney Cancer - The Cytokine Working Group Experience (1986-2001) Part I. IL2 Based Clinical Trials.
Atkins MB, Dutcher JP, Weiss G, Margolin K, Clark J, Sosman J, Logan T, Aronson F, Mier, Medical Oncology 2001; 18; 189-196
Introduction: High dose Interleukin-2 in metastatic disease: Renal cell carcinoma and melanoma.
Dutcher JP, Oncology 2002; 16 (11) Suppl, pp 1-2
Current status of interleukin-2 therapy for metastatic renal cell carcinoma and metastatic melanoma.
Dutcher JP, Oncology 2002; 16 (11) Suppl, pp 3-10
New Results in Treatment of Metastatic Renal Cell Cancer with IL-2.
Dutcher JP, CME Monograph sponsored by University of Wisconsin, Madison, WI
Case Studies in Oncology: Interleukin-2 in the Treatment of Metastatic Renal Cell Carcinoma.
Alexandrescu DT, Dutcher JP, CME Monograph sponsored by Baylor Cancer Center, Dallas, TX
Metastatic Melanoma: Is Biochemotherapy the future?
Alexandrescu DT, Dutcher JP, Wiernik PH, Medical Oncology 2005; 22; 101-112
mTOR Inhibition in the Clinic.
Dutcher JP, Kidney Cancer Journal, (Suppl) 2008; p9-12
Join now to see all